Immunoelectron microscopic evidence for release of eosinophil granule matrix protein onto microfilariae of Onchocerca volvulus in the skin after exposure to amocarzine.
The involvement of eosinophils in the host reaction to microfilariae (mf) of Onchocerca volvulus was studied by immunohistochemistry and immunoelectron microscopy. Skin biopsies were obtained from patients after transepidermal administration of the microfilaricide amocarzine. At 20-28 h after the application of amocarzine, mf were degenerated or dead and a marked eosinophil-parasite adherence (EPA) reaction was seen, with intense staining for intra- and extracellular eosinophil granule proteins such as eosinophil cationic protein (ECP) surrounding the mf. Immunoelectron microscopically the eosinophil granule matrix in intact and necrotic eosinophils was specifically labeled, whereas granules whose matrix had dissolved showed no specific gold particle binding. As specific labeling was seen on lowly electron-dense material adjacent to matrix-depleted granules, the material was regarded as released eosinophil granule matrix material. Intact and necrotic eosinophils, matrix-containing as well as matrix-depleted eosinophil granules, and released eosinophil granule matrix material were observed on the surface of damaged mf and between collagen fibers. The coincidence of mf degeneration, EPA reaction, and release of eosinophil granule matrix material on damaged mf and collagen fibers indicated a role of eosinophils and eosinophil granule matrix protein in the host reaction to mf after amocarzine application.
Gutiérrez-Peña
E J
EJ
Department of Helminthology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Knab
J
J
Büttner
D W
DW
D000328:Adult; D000818:Animals; D001798:Blood Proteins / Q000032:analysis*; D003594:Cytoplasmic Granules / Q000737:chemistry / Q000648:ultrastructure; D047091:Eosinophil Granule Proteins; D047208:Eosinophil-Derived Neurotoxin; D004804:Eosinophils / Q000737:chemistry / Q000648:ultrastructure*; D005260:Female; D005369:Filaricides / Q000627:therapeutic use; D006801:Humans; D007150:Immunohistochemistry; D018836:Inflammation Mediators / Q000032:analysis; D008297:Male; D016253:Microscopy, Immunoelectron; D008875:Middle Aged; D017181:Onchocerca volvulus / Q000648:ultrastructure*; D009855:Onchocerciasis / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology*; D010879:Piperazines / Q000627:therapeutic use*; D012260:Ribonucleases; D012867:Skin / Q000737:chemistry / Q000469:parasitology / Q000648:ultrastructure*
D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D005369:Filaricides; D018836:Inflammation Mediators; D010879:Piperazines; C051744:amocarzine; D047208:Eosinophil-Derived Neurotoxin; D012260:Ribonucleases